Literature DB >> 15644176

Mechanistic insights aid computational short interfering RNA design.

Queta Boese1, Devin Leake, Angela Reynolds, Steven Read, Stephen A Scaringe, William S Marshall, Anastasia Khvorova.   

Abstract

RNA interference is widely recognized for its utility as a functional genomics tool. In the absence of reliable target site selection tools, however, the impact of RNA interference (RNAi) may be diminished. The primary determinants of silencing are influenced by highly coordinated RNA-protein interactions that occur throughout the RNAi process, including short interfering RNA (siRNA) binding and unwinding followed by target recognition, cleavage, and subsequent product release. Recently developed strategies for identification of functional siRNAs reveal that thermodynamic and siRNA sequence-specific properties are crucial to predict functional duplexes (Khvorova et al., 2003; Reynolds et al., 2004; Schwarz et al., 2003). Additional assessments of siRNA specificity reveal that more sophisticated sequence comparison tools are also required to minimize potential off-target effects (Jackson et al., 2003; Semizarov et al., 2003). This chapter reviews the biological basis for current computational design tools and how best to utilize and assess their predictive capabilities for selecting functional and specific siRNAs.

Mesh:

Substances:

Year:  2005        PMID: 15644176     DOI: 10.1016/S0076-6879(04)92005-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  24 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 2.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 3.  Toward a complete in silico, multi-layered embryonic stem cell regulatory network.

Authors:  Huilei Xu; Christoph Schaniel; Ihor R Lemischka; Avi Ma'ayan
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 4.  Silencing disease genes in the laboratory and the clinic.

Authors:  Jonathan K Watts; David R Corey
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

5.  RNA interference in human foreskin fibroblasts within the three-dimensional collagen matrix.

Authors:  Mark A Carlson; Amy K Prall; Jeremiah J Gums
Journal:  Mol Cell Biochem       Date:  2007-07-27       Impact factor: 3.396

6.  Effect of target secondary structure on RNAi efficiency.

Authors:  Yu Shao; Chi Yu Chan; Anil Maliyekkel; Charles E Lawrence; Igor B Roninson; Ye Ding
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

7.  Production of highly potent recombinant siRNAs in Escherichia coli.

Authors:  Linfeng Huang; Judy Lieberman
Journal:  Nat Protoc       Date:  2013-10-31       Impact factor: 13.491

8.  Combination of RNA interference and U1 inhibition leads to increased inhibition of gene expression.

Authors:  X Abad; N Razquin; A Abad; P Fortes
Journal:  Nucleic Acids Res       Date:  2010-04-28       Impact factor: 16.971

9.  96 shRNAs designed for maximal coverage of HIV-1 variants.

Authors:  Glen John McIntyre; Jennifer Lynne Groneman; Yi-Hsin Yu; Angel Jaramillo; Sylvie Shen; Tanya Lynn Applegate
Journal:  Retrovirology       Date:  2009-06-04       Impact factor: 4.602

10.  Delivery of RNAi reagents in murine models of obesity and diabetes.

Authors:  Denise M Wilcox; Ruojing Yang; Sherry J Morgan; Phong T Nguyen; Martin J Voorbach; Paul M Jung; Deanna L Haasch; Emily Lin; Eugene N Bush; Terry J Opgenorth; Peer B Jacobson; Christine A Collins; Cristina M Rondinone; Terry Surowy; Katherine T Landschulz
Journal:  J RNAi Gene Silencing       Date:  2006-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.